Background: We previously reported increased risk of breast cancer associated with early life exposure to two measures of air pollution exposure, total suspended particulates (TSP) and traffic emissions (TE), possible proxies for exposure to polycyclic aromatic hydrocarbons (PAHs). Exposure to PAHs has been shown to be associated with aberrant patterns of DNA methylation in peripheral blood of healthy individuals. Exposure to PAHs and methylation in breast tumor tissue has received little attention. We examined the association of early life exposure to TSP and TE with patterns of DNA methylation in breast tumors. Methods: We conducted a study of women enrolled in the Western New York Exposures and Breast Cancer (WEB) Study. Methylation of nine genes (SFN, SCGB3A1, RARB, GSTP1, CDKN2A CCND2, BRCA1, FHIT, and SYK) was assessed using bisulfite-based pyrosequencing. TSP exposure at each woman's home address at birth, menarche, and when she had her first child was estimated. TE exposure was modeled for each woman's residence at menarche, her first birth, and twenty and ten years prior to diagnosis. Unconditional logistic regression was employed to estimate odds ratios (OR) of having methylation greater than the median value, adjusting for age, secondhand smoke exposure before age 20, current smoking status, and estrogen receptor status. Results: Exposure to higher TSP at a woman's first birth was associated with lower methylation of SCGB3A1 (OR = 0.48, 95% CI: 0.23-0.99) and higher methylation of SYK (OR = 1.86, 95% CI: 1.03-3.35). TE at menarche was associated with increased methylation of SYK (OR = 2.37, 95% CI: 1.05-5.33). TE at first birth and ten years prior to diagnosis was associated with decreased methylation of CCND2 (OR ten years prior to diagnosis=0.48, 95% CI: 0.26-0.89). Although these associations were nominally significant, none were significant after adjustment for multiple comparisons (p < 0.01). Conclusions: We observed suggestive evidence that exposure to ambient air pollution throughout life, measured as TSP and TE, may be associated with DNA methylation of some tumor suppressor genes in breast tumor tissue. Future studies with a larger sample size that assess methylation of more sites are warranted.
Introduction
Polycyclic aromatic hydrocarbons (PAHs) are a class of compounds formed by combustion of organic material that are known to cause lung cancer in humans and mammary tumors in animals (IARC, 2010) . The evidence of an association between PAHs breast cancer in humans is less consistent. Various proxy measures of exposure to PAHs, such as particulate matter (PM) or detectable PAH-DNA adducts have been demonstrated to be associated with increased risk of breast cancer in many (Bonner et al., 2005; Brody et al., 2007; Chen and Bina, 2012; Hu et al., 2013; Huo et al., 2013; Hystad et al., 2015; Wei et al., 2011) , but not all studies (Reding et al., 2015) . Exposure to PM has also been associated with poorer breast cancer prognosis (Hu et al., 2013; Huo et al., 2015) as well as tumor characteristics associated with poor prognosis, including higher tumor-nodal-metastasis stage and histologic grade (Huo et al., 2013) . We previously reported that postmenopausal women residentially exposed to high concentrations of total suspended particles (TSP) at birth were at greater odds of being a breast cancer case (Bonner et al., 2005) , and premenopausal women exposed to higher traffic emissions (TE) at menarche and postmenopausal women exposed to higher TE at first birth also had a higher risk of breast cancer (Nie et al., 2007) .
Evidence is increasing that epigenomic alterations may be an important link between health effects of the environment and genetics (De Prins et al., 2013; Moore et al., 2003; Pavanello et al., 2009) . There is frequent aberrant methylation of CpG islands in cancer cells, associated with abnormal silencing of tumor suppressor and other cancer related genes (Lim et al., 2008; Lodygin and Hermeking, 2005; McCabe et al., 2009; Moore et al., 2003; Vaissiere et al., 2008) . Hypermethylation of tumor suppressor genes has been associated with more invasive breast cancers (Kajabova et al., 2013) and may be a potential biomarker for poorer breast cancer prognosis (Cho et al., 2012; Tao et al., 2009; Xu et al., 2012) .
In healthy individuals, exposure to PM or constituents of PM has been associated with aberrant patterns of DNA methylation in peripheral blood (Baccarelli et al., 2009; Bellavia et al., 2013; Bollati et al., 2007; Byun et al., 2013; Guo et al., 2014; Hou et al., 2011; Janssen et al., 2013; Kile et al., 2013; Kleinman et al., 2008; Madrigano et al., 2011; Pavanello et al., 2009; Peluso et al., 2012; Soberanes et al., 2012) , placental tissue (Janssen et al., 2013) , and umbilical cord blood (Tang et al., 2012) . However, DNA methylation is tissue-specific (Johnson et al., 2014) . However, only two studies have assessed the association between exposure to PAHs and methylation patterns of breast tumor tissue (Pirouzpanah et al., 2010; White et al., 2015) .
Exposure to sources of PAHs in the year prior to breast cancer diagnosis was associated with methylation of 13 breast cancer-related genes in breast tumor tissue in one prior study (White et al., 2015) . However, because altered DNA methylation is posited as an early event in breast carcinogenesis (Johnson et al., 2015; Muggerud et al., 2010) assessing exposure to PAHs throughout life may better identify an etiologically relevant window of exposure and reduce the potential for exposure misclassification. Exposures occurring during the perinatal period, menarche, and the time of a woman's first birth are hypothesized to be of importance in breast carcinogenesis because of the rapid cell proliferation and differentiation that occurs (Colditz et al., 2014) . Therefore, it is likely that some exposures are important only when they occur during the relevant window of susceptibility. Thus, we hypothesized that the association between exposure to PAHs and alterations in DNA methylation in breast tumor tissue depends on the timing of exposure.
We examined the association between two proxy measures of exposure to PAHs at several potentially sensitive periods throughout life with DNA methylation of nine genes in a large population-based sample of breast cancer cases. We hypothesized that methylation of genes implicated in the etiology of breast cancer are related to exposure to PAHs.
Materials and methods
Detailed study methods have been published previously (Bonner et al., 2005; Brasky et al., 2011; Callahan et al., 2016; Nie et al., 2007) . Briefly, the Western New York Exposures and Breast Cancer (WEB) study was a population-based case-control study of breast cancer. Cases were 1170 women with primary, histologically confirmed, incident breast cancer who were 35-79 years of age at diagnosis, and interviewed within one year of diagnosis. During the in-person interview, participants were queried on breast cancer risk factors including race; age; education; smoking history; medical history; reproductive history; and residential and occupational secondhand smoke exposure, including from participants' parents, at several points in time. All participants provided informed consent, and the study protocol was C.L. Callahan et al. Environmental Research 161 (2018) [418] [419] [420] [421] [422] [423] [424] approved by the Institutional Review Boards of the University at Buffalo and of all participating institutions.
Exposure assessment
Analyses were restricted to women who resided in Erie and Niagara County for whom we were able to identify a residence at each of the relevant time periods and successfully geocode. Exposures were measured based on lifetime residential histories provided by the participants and available environmental monitoring data. The methods used to estimate of WEB study participants' exposure to TSP have been described previously (Bonner et al., 2005) . Briefly, annual average TSP concentrations were obtained from New York State Department of Environmental Conservation air monitors that began measuring TSP in 1959. Inverse distance squared weighed interpolation was used to generate prediction maps of TSP concentrations at a particular location based on monitor readings using ArcGIS 8.0 (ESRI), which were used to estimate exposure to TSP at each participant's address based on their reported residential histories.
The methods used to estimate residential exposure to traffic related air pollution have been reported previously (Nie et al., 2007) . We developed a Buffalo/Niagara version of a geographic traffic exposure model used in the Long Island Breast Cancer Study (Beyea et al., 2006) . Meteorological and traffic data were used to generate a region-specific traffic dispersion model to estimate traffic emissions, especially PAHs. This model produces relative estimates of exposure, which are less sensitive to model uncertainties.
Pyrosequencing
Tumor samples were microdissected with a fine needled under a microscope limiting the amount of surrounding stromal and normal cells included in the dissection, a separate hematoxylin and eosin stained slide was used as a guide (Tennis et al., 2006) . Only regions with at least 80% tumor cells on them were used for DNA extraction, this was verified by a certified and experienced breast pathologist. Genomic DNA (500 ng) was treated with sodium bisulfite using the EZ DNA Methylation kit (Zymo Research, Orange, CA). Archived tumor blocks were obtained from participants with their consent. Genes that had previously been reported to be methylated in breast cancer and which had biological significance in carcinogenesis (Arai et al., 2006; Cheol Kim et al., 2012; Feng et al., 2010; Hsu et al., 2013; Jeong et al., 2013; Klajic et al., 2013; Marzese et al., 2012; Xu et al., 2011; Zhang et al., 2009) were selected for methylation analysis. The genes assessed in this analysis were: stratifin (SFN); secretoglobin, family 3A, member 1 (SCGB3A1); retinoic acid receptor, beta (RARB); glutathione Stransferase pi 1 (GSTP1); cyclin-dependent kinase inhibitor 2 A (CDKN2A); cyclin D2 (CCND2); breast cancer gene 1 (BRCA1); fragile histidine triad (FHIT); and spleen tyrosine kinase (SYK). We used the PyroMark MD Pyrosequencing system (Qiagen, Valencia, CA) to detect methylated CpG sites in sequencing reactions (Tost and Gut, 2007) . Bisulfite-treated DNA was amplified with specific primers for the promoter region of each gene. The Pyro Mark Assay Design program and the Pyro Q-CpG software were used for primer designs and data analysis, respectively. Ten percent of total samples were assayed in duplicate for each gene for quality control purposes. Additionally, as a positive control, human methylated and non-methylated DNA (Zymo Research, Orange, CA) were used along with water blanks as a negative control. Primer sets, SYK (Cat. # PM00151816), SCGB3A1 (Cat. #PM00022687), GSTP1 (Cat. # PM00151809), CDKN2A (Cat. # 972012), and CCND2 (Cat. #PM00051674) were purchased from Qiagen.
Statistical analyses
Site specific methylation percentages were determined for 4-10 CpG sites for each gene. Methylation of individual CpG sites was averaged for each gene for each participant. Differences in the median methylation levels by participants' characteristic and exposures were evaluated using the Kruskal-Wallis test. Unconditional logistic regression was employed to estimate odds ratios (OR) and 95% confidence intervals (CI) for odds of methylation above the median value for each gene.
We considered three potentially relevant windows of exposure to TSP, at the time of the woman's birth, menarche, and her first birth. Variability in TSP exposure among WEB study participants during adulthood was limited because TSP concentrations began to decrease during the 1970's and through the 1990's. Thus, we did not consider exposures to TSP after a woman's first birth in this analysis. Exposure to TSP for each time point was dichotomized at the median value of TSP exposure at birth (134 µg/m 3 ). We also evaluated the potential exposure-response gradient between TSP exposure and methylation using a five-knot cubic regression spline in the unconditional logistic regression models.
TE exposure was considered for four time periods, menarche, first birth, 20 years prior to diagnosis, and ten years prior to diagnosis. TE estimates were dichotomized based on the median value among breast cancer controls, which varied based on menopausal status and the timewindows considered, i.e., premenopausal women at menarche analysis (8.36), premenopausal women at first birth analysis (7.41), postmenopausal women at first birth analysis (8.35), premenopausal women at 20 years prior analysis (7.73), postmenopausal women at 20 years prior analysis (7.72), premenopausal women at 10 years prior analysis (6.15), and postmenopausal women at 10 years prior analysis (6.29). TE exposure at a woman's own birth was not assessed because a Odds ratios (OR) for methylation above the median value and 95% confidence intervals (CI) were estimated with unconditional logistic regression model adjusted for age in years, estrogen receptor status, current smoking status, secondhand smoke exposure before age 20, and menopausal status. Abbreviations: M, methylated; UM, unmethylated; OR, odds ratio; SFN, stratifin; SCGB3A1, secretoglobin, family 3A, member 1; RARB, retinoic acid receptor, beta; GSTP1, glutathione S-transferase pi 1; CDKN2A, cyclin-dependent kinase inhibitor 2 A; CCND2, cyclin D2; BRCA1, breast cancer gene 1; FHIT, fragile histidine triad; SYK, spleen tyrosine kinase.
C.L. Callahan et al. Environmental Research 161 (2018) [418] [419] [420] [421] [422] [423] [424] we were constrained by the availability of historical data, which began in 1960.
Covariates considered for adjustment in regression models were age at interview, age at menarche, parity, body mass index, secondhand smoke exposure throughout life, active cigarette smoking, family history of breast cancer, and alcohol consumption. We also considered tumor characteristics including histological grade; tumor size; and estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and triple negative statuses. Covariates were included in the final model if they changed the association between TSP exposure at birth and average methylation of the nine genes by 10% or were hypothesized to important potential confounders. Final models were adjusted for age at interview (continuous), ER status, secondhand smoke exposure before age 20 (yes, no), and current smoking status (never, former, current). ER status was included in the models because we had previously reported that it was associated with methylation of several genes (Callahan et al., 2016) . Effect measure modification by cigarette smoking and ER status were assessed via a stratified analysis. We assessed potential statistical interaction on the multiplicative scale by including an interaction term in adjusted models.
All p-values reported are two-sided and statistical significance was defined as p < 0.05. To adjust for multiple comparisons, we also generated Bonferroni-corrected 99% CIs (1-0.05/9 = 0.99). Statistical analyses were conducted using SPSS version 21.00 (IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp) and SAS Enterprise Guide version 4.3 (SAS Institute, Cary, NC).
Results
Descriptive characteristics of cases included in these analyses are presented in Table 1 . Most of the participants were postmenopausal (69%). Increased Methylation of SFN and SCGB3A1 were associated with ER status. Median TSP exposure was highest at birth (134 µg/m 3 vs. 127 at menarche and 110 at first birth).
The associations between residential TSP exposures at participants' first birth with methylation above the median value among breast cancer cases are presented in Table 2 . We did not observe any significant associations with methylation of an individual gene and TSP exposure at birth or menarche (not shown). TSP exposure greater than 134 µg/m 3 at the time of the woman's first birth was inversely associated with methylation of SCGB3A1 (OR = 0.48, 95% CI: 0.23-0.99) Fig. 1 . Odds ratios for methylation above the median for different levels of total suspended particulate (TSP) exposure at first birth compared to 47.6 µg/m 3 (12.5th percentile). The solid line shows the fitted five-knot spline relationship; the dashed lines are the point-wise upper and lower 95% CIs. Adjusted for age in years, estrogen receptor status, current smoking status, secondhand smoke exposure before age 20, and menopausal status.
C.L. Callahan et al.
Environmental Research 161 (2018) [418] [419] [420] [421] [422] [423] [424] and positively associated with methylation of SYK (OR = 1.86, 95% CI: 1.03-3.35). The spline regression analyses for TSP exposure at first birth did not show any statistically significant exposure-response gradients (Fig. 1) . Results of TE exposure analyses are presented in Table 3 . Cases exposed to greater than the median value of TE at menarche were more likely to have higher methylation of SYK (OR = 2.37, 95% CI: 1.05-5.33). TE exposure at menarche was not associated with methylation of other individual genes or average methylation. Cases exposed to TE above the median value at first birth or ten years prior to diagnosis had decreased methylation of CCND2 (adjusted OR first birth = 0.40, 95% CI: 0.17-0.93, adjusted OR ten years prior to diagnosis = 0.48, 95% CI: 0.26-0.89). Methylation of other individual genes was not associated with TE exposure at first birth or ten years prior to diagnosis. TE exposure 20 years prior to diagnosis was not associated with methylation of any gene (results not shown) although we did observe a suggestive association between TE exposure 20 years prior to diagnosis and lower methylation of CCND2 (adjusted OR 20 years prior to diagnosis= 0.55, 95% CI: 0.30-1.00).
When analyses were stratified by smoking status the inverse association between TSP exposure at birth and decreased average methylation was attenuated among never smokers (adjusted OR = 0.63, 95% CI: 0.31-1.26) but persisted among ever smokers (adjusted OR = 0.40, 95% CI: 0.20-0.82), the test for multiplicative interaction was not statistically significant. Among never smokers, the only significant association we observed was with TSP exposure at menarche was and increased methylation of GSTP1 (adjusted OR: never smokers = 2.61, 95% CI: 1.18-5.74, ever smokers= 0.86, 95% CI: 0.42-1.78, p for interaction = 0.06). Among ever smokers, TSP exposure during any time was not associated with methylation of any individual gene. The inverse associations between methylation of CCND2 and TE exposure at first birth or ten years prior to diagnosis persisted among never smokers (adjusted OR first birth = 0.15, 95% CI: 0.04-0.69, adjusted OR ten years prior = 0.23, 95% CI: 0.10-0.78) but was attenuated when analyses were restricted to ever smokers (adjusted OR first birth = 0.66, 95% CI: 0.20-2.21, adjusted OR ten years prior: 0.60, 95% CI: 0.26-1.37), tests for multiplicative interaction were not statistically significant. TE exposure at menarche was inversely associated with BRCA1 methylation among ever smokers only (adjusted OR = 0.21, 95% CI: 0.06-0.75, p for interaction = 0.05). We did not observe evidence that the association between exposure to TSP or TE and methylation of any other gene was modified by cigarette smoking (results not shown).
There was not strong evidence of effect modification by menopausal status or ER status (results not shown). None of our results for exposure to TSP or TE were significant at the more stringent level of p < 0.01 and all of the 99% CIs included the null value (Tables 2 and 3 ).
Discussion
We observed suggestive differences in DNA methylation in breast tumors by exposure to air pollution throughout the lifetime. TSP exposure at first birth was associated with decreased methylation of SCGB3A1 and increased methylation of SYK. Increased exposure to TE at menarche was also associated with higher methylation of SYK. TE exposure at first birth, twenty years prior to diagnosis, and ten years prior to diagnosis were associated with decreased methylation of CCND2. Our results are consistent with the hypothesis that early-life exposures may impact epigenetic programming and persist until later life. We have previously demonstrated that early life exposures, low birth weight, birth order, and not having been breastfed were associated with breast tumor DNA methylation of other genes in tumors a Odds ratios (OR) for methylation above the median value and 95% confidence intervals (CI) were estimated with unconditional logistic regression model adjusted for age in years, estrogen receptor status, current smoking status, secondhand smoke exposure before age 20, and menopausal status. Abbreviations: M, methylated; UM, unmethylated; OR, odds ratio; SFN, stratifin; SCGB3A1, secretoglobin, family 3A, member 1; RARB, retinoic acid receptor, beta; GSTP1, glutathione Stransferase pi 1; CDKN2A, cyclin-dependent kinase inhibitor 2 A; CCND2, cyclin D2; BRCA1, breast cancer gene 1; FHIT, fragile histidine triad; SYK, spleen tyrosine kinase.
C.L. Callahan et al. Environmental Research 161 (2018) 418-424 from these women (Tao et al., 2013) . Estimated TSP and TE are proxy measures for exposure to PAHs. PAHs resulting from incomplete combustion are ubiquitous pollutants that have been implicated in breast carcinogenesis; several epidemiologic studies using air pollution as a proxy measure of exposure to PAH have supported this hypothesis (Bonner et al., 2005; Mordukhovich et al., 2015) . Results of other epidemiologic studies have been less consistent and suggest the association may be restricted to either hormone receptor positive (Reding et al., 2015) or hormone receptor negative subtypes (Liu et al., 2015) . We did not find evidence of effect modification by ER status.
Our observed findings of associations between sources of PAH exposure and both increased and decreased methylation is consistent with the small number of previous studies of PAH exposure and breast tumor methylation. There are several possible mechanisms by which PAHs may lead to both increased or decreased methylation, which remain to be fully elucidated. These include inhibition of DNA methyltransferases (Wilson and Jones, 1983) leading to hypomethylation. In addition, it has been demonstrated that methyl groups bind preferentially to damaged DNA, including PAH DNA adducts (Chappell et al., 2016; James et al., 2003) . Breast cancer cells treated in vitro with benzo-a-pyrene, a PAH commonly found in PM, showed both hypo-and hypermethylation in four breast carcinoma cell lines examined (Sadikovic and Rodenhiser, 2006) . To our knowledge, one prior study has assessed multiple sources of PAH exposure and methylation of 13 breast cancer related genes in breast tumor tissue; that study examined exposures at the time of diagnosis (White et al., 2015) . Exposure to TE, estimated using the same model we used, was associated with higher TWIST1 methylation (OR = 2.79, 95% CI: 1.24-6.30), a gene which we did not assess. Environmental tobacco smoke exposure was associated with decreased methylation of CCND2 (OR = 0.65, 95% CI: 0.44-0.96) (White et al., 2015) . Similarly, we observed that traffic emissions exposure in the decades prior to diagnosis were consistently associated with decreased methylation of CCND2. Our results suggest that ambient exposures to PAH may impact DNA methylation patterns earlier in carcinogenesis, and may persist until later life. We also observed an association between increased methylation of SYK and traffic exposure at menarche.
Inferences from our study need to be made in the context of several limitations. TSP is a relatively crude proxy for exposure to PM. PM 2.5 is considered to be the most biologically relevant measure because it is absorbed into the lower levels of the lungs and distributed into the bloodstream (Strak et al., 2012; Valavanidis et al., 2008; Wong et al., 2014) . However, TSP is the most suitable measure for historical exposures because it was the only measure of PM consistently collected in the early 1960's (Bonner et al., 2005; Cedar and Bergman, 2012) . We would expect the misclassification of exposure to be non-differential with regards to methylation status; our results may be biased towards the null. Additionally, our results may reflect other constituents of TSP or traffic-related air pollution as well as PAHs. Furthermore, we had did not consider occupational sources of exposure to PAHs, except secondhand smoke.
We selected a limited number of genes based on their relevance to breast carcinogenesis; we cannot extrapolate our findings to other genes or surrogate measures of global methylation that were not assessed in this study. Additionally, we did not measure methylation in "normal" or benign breast tissue in these women. Thus, it is possible that the differences in methylation we observed may not be tumor specific. However, we note that if we did measure methylation in adjacent normal tissue these markers could still be a field effect of the tumor itself and DNA methylation in breast tumors is not well correlated with methylation of the same genes in blood or normal breast tissue (Wojdacz et al., 2011) .
Our study also had limited statistical power, resulting from missing data for cases without available tumor and who were not residents of the two counties during the periods of interest, and a small sample size for some of the time-points assessed. Previous studies of DNA methylation and air pollution exposure have generally reported modest effect sizes (Breton and Marutani, 2014; De Prins et al., 2013; Janssen et al., 2013; Peluso et al., 2012) . There was also limited variability in exposure at some points in time. For instance, cases in our study were generally exposed to high levels of TSP at birth, median TSP exposure at birth for participants included in these analyses was 134 µg/m 3 (interquartile range = 35 µg/m 3 ), while the EPA guidelines for TSP in 1971
were 75 µg/m 3 (http://www.epa.gov/ttn/naaqs/standards/pm/ s_pm_history.html). TSP could only be estimated for women born in Erie and Niagara County. Tumor methylation data for cases included in these analyses was similar to those that were not included; median average methylation was 18.78% and 18.80%, respectively. We also did not have DNA methylation data for 145 cases for whom TSP exposure at birth information was available because tumor tissue was not available from these women. Distribution of TSP exposure at birth was not different for this group. The cases excluded from these analyses did reduce the power of these analyses. While adjustment for potential confounders did not substantially change the observed point estimates, the small sample size also limited the adjustment for potential confounders.
We made several comparisons and most of our findings were only nominally significant. We note that some of our findings may be due to chance and require replication in larger studies with more statistical power.
Our study provides an important contribution to the expanding body of research indicating that PAHs are associated with aberrant patterns of methylation that may lead to carcinogenesis. It has several important strengths. Because of the relative residential stability of our study participants, we were able to examine exposures in several critical windows of potential susceptibility including early life as well as those closer to the time of diagnosis for a substantial proportion of the study participants. We measured DNA methylation in target tissue. Further, we used historical measures of air pollution minimizing potential recall bias and examining the potentially relevant windows of exposure. Using recent PAH exposure is not an appropriate proxy for early exposure. In our study, exposure to TSP at birth was not correlated with adult exposure to TSP ten years prior to diagnosis (Spearman ρ = 0.09).
In conclusion, we observed suggestive evidence that methylation of specific genes may be associated with exposure to total suspended particulates at first birth and traffic emissions at menarche, first birth, and 20 and 10 years prior to diagnosis. This is the first study to report on the association between methylation of breast tumor tissue and these exposures from multiple points in time. Further research of exposure to PAH and methylation of both benign and malignant breast tissue examining DNA methylation in the genome more broadly in larger studies is warranted.
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